Cedrone Fabrizio, Di Martino Giuseppe, Di Giovanni Pamela, Greco Emilio, Trebbi Edoardo, Romano Ferdinando, Staniscia Tommaso
Local Health Authority of Pescara, Via Paolini, 65100 Pescara, Italy.
Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.
Healthcare (Basel). 2022 May 9;10(5):871. doi: 10.3390/healthcare10050871.
(1) Background: The COVID-19 pandemic has indirect consequences for healthcare for other diseases, known as collateral damage. This situation heavily affects healthcare systems, causing changes in patterns of hospital admission. During the peak of the coronavirus disease 2019 pandemic, numerous studies reported a reduction in admissions for acute coronary syndrome. The aim of this study was to evaluate the incidence of admissions for cardiovascular diseases in Abruzzo, a region of Southern Italy, in the year 2020 and compare it to the two previous years (2018−2019). (2) Methods: This retrospective study was conducted in Abruzzo, Italy. The monthly number of admissions in the year 2020 was compared to a control period made from the average number of events that occurred in the previous two years (2018−2019). (3) Results: A global reduction in hospital admissions for all the cardiovascular diseases (CVDs) considered was observed. In particular, compared to the control period, in 2020, the number of admissions for ST-segment elevation myocardial infarction (STEMI) was lower by 34 (hospitalization rate ratio, HRR, 0.93; p < 0.001), the number of non-ST-segment-elevation myocardial infarctions (N-STEMI) was lower by 154.5 (HRR 0.89; p < 0.001), the number for acute coronary syndrome (ACS) was 340 lower (HRR 0.90; p < 0.001) and the number for heart failure (HF) was 1424.5 lower than during the control period (HRR 0.73; p < 0.001). (4) Conclusions: The results of this study show the impact of COVID-19 on admissions for CVDs, suggesting the need for strategic measures to overcome the burden of hospitalizations in future years.
(1) 背景：2019冠状病毒病疫情对其他疾病的医疗保健产生了间接影响，即所谓的附带损害。这种情况严重影响了医疗保健系统，导致医院入院模式发生变化。在2019冠状病毒病疫情高峰期，众多研究报告称急性冠状动脉综合征的入院人数有所减少。本研究的目的是评估意大利南部阿布鲁佐地区2020年心血管疾病的入院发生率，并将其与前两年（2018 - 2019年）进行比较。(2) 方法：本回顾性研究在意大利阿布鲁佐地区进行。将2020年的月度入院人数与由前两年（2018 - 2019年）发生的事件平均数量构成的对照期进行比较。(3) 结果：观察到所考虑的所有心血管疾病（CVD）的医院入院人数总体减少。特别是，与对照期相比，2020年ST段抬高型心肌梗死（STEMI）的入院人数减少了34例（住院率比，HRR，0.93；p < 0.001），非ST段抬高型心肌梗死（N - STEMI）的入院人数减少了154.5例（HRR 0.89；p < 0.001），急性冠状动脉综合征（ACS）的入院人数减少了340例（HRR 0.90；p < 0.001），心力衰竭（HF）的入院人数比对照期减少了1424.5例（HRR 0.73；p < 0.001）。(4) 结论：本研究结果显示了2019冠状病毒病对心血管疾病入院人数的影响，表明需要采取战略措施来应对未来几年的住院负担。
